Tarsus Pharmaceuticals Inc. TARS
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Tarsus Pharmaceuticals Inc. is a biopharmaceutical company dedicated to developing and commercializing therapeutics for the treatment of ophthalmic conditions. The company’s primary focus is on innovative treatments that address significant unmet medical needs in eye care, particularly in diseases affecting the anterio…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees370
TickerTARS
Statistics
Market Cap$2.69B
Revenue (TTM)$451.4M
Net Income-$66.4M
Net Margin-14.7%
EPS$-1.59
P/E-39.38
P/S5.03
P/B7.76
EV/EBITDA-47.66
ROE-14.0%
Dividend Yield—
Price$62.45
Data: Twelve Data · Revenue = mcap / P/S